Home LiteratureArticle Details
PMID: 11870514 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas.

British journal of cancer ·Vol. 86 ·No. 2 ·2002-01-21 ·Pages 244-9

Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A, Granone P, Nicholson AG, Goldstraw P, Ratcliffe C, Tetlow M, Leigh I, Harris AL, Gatter KC, Pezzella F

Abstract

We have previously described a group of non-small cell lung carcinomas without morphological evidence of neo-angiogenesis. In these tumours neoplastic cells fill up the alveoli and the only vessels present appear to belong to the trapped alveolar septa. In the present study we have characterised the phenotype of the vessels present in these non-angiogenic tumours, in normal lung and in angiogenic non-small cell lung carcinomas. The vessels, identified by the expression of CD31, were scored as mature when expressing the epitope LH39 in the basal membrane and as newly formed when expressing alphaVbeta3 on the endothelial cells and/or lacking LH39 expression. In the nine putative non-angiogenic cases examined, the vascular phenotype of all the vessels was the same as that of alveolar vessels in normal lung: LH39 positive and alphaVbeta3 variable or negative. Instead in 104 angiogenic tumours examined, only a minority of vessels (mean 13.1%; range 0--60%) expressed LH39, while alphaVbeta3 (in 45 cases) was strongly expressed on many vessels (mean 55.5%; range 5--90%). We conclude that in putative non-angiogenic tumours the vascular phenotype is that of normal vessels and there is no neo-angiogenesis. This type of cancer may be resistant to some anti-angiogenic therapy and different strategies need to be developed.

MeSH Terms
Carcinoma, Non-Small-Cell Lung/blood supply,immunology,pathology Drug Resistance Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Lung Neoplasms/blood supply,immunology,pathology Neovascularization, Pathologic Phenotype Platelet Endothelial Cell Adhesion Molecule-1/analysis Regional Blood Flow
Chemicals
Platelet Endothelial Cell Adhesion Molecule-1
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Passalidou E
3rd Department of Respiratory Medicine, Sismanogleiou Hospital, Sismanogleiou 1, PC 15126 Athens, Greece.
Trivella M
Singh N
Ferguson M
Hu J
Cesario A
Granone P
Nicholson A G
Goldstraw P
Ratcliffe C
Tetlow M
Leigh I
Harris A L
Gatter K C
Pezzella F
References (28)
28 references, click to expand
  1. Requirement of vascular integrin alpha v beta 3 for angiogenesis.
    Science. 1994 Apr 22;264(5158):569-71 PMID: 7512751
  2. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.
    Oncogene. 1999 Sep 20;18(38):5356-62 PMID: 10498889
  3. The association between tumour progression and vascularity in the oral mucosa.
    J Pathol. 1997 Sep;183(1):39-43 PMID: 9370945
  4. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.
    Clin Cancer Res. 2000 Aug;6(8):3056-61 PMID: 10955784
  5. Expression of cell adhesion molecules by microvascular endothelial cells in the cortical and subcortical regions of the normal human brain: an immunohistochemical analysis.
    Neuropathol Appl Neurobiol. 1997 Feb;23(1):68-80 PMID: 9061692
  6. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
    Cancer Res. 1999 Nov 1;59(21):5602-7 PMID: 10554041
  7. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.
    Cell. 1996 Aug 9;86(3):353-64 PMID: 8756718
  8. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
    Cancer Res. 1994 Feb 15;54(4):1119-29 PMID: 8313370
  9. The Significance of Hyperemia Around Tumor Implants.
    Am J Pathol. 1946 Jul;22(4):821-31 PMID: 19970893
  10. Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells.
    Acta Neuropathol. 1993;86(2):117-25 PMID: 8213067
  11. Tumor angiogenesis: therapeutic implications.
    N Engl J Med. 1971 Nov 18;285(21):1182-6 PMID: 4938153
  12. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39.
    Br J Cancer. 2000 Feb;82(4):844-51 PMID: 10732757
  13. Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney.
    Am J Nephrol. 1996;16(5):402-8 PMID: 8886177
  14. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.
    Am J Pathol. 1997 Nov;151(5):1417-23 PMID: 9358768
  15. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Am J Pathol. 1999 Sep;155(3):739-52 PMID: 10487832
  16. What is the evidence that tumors are angiogenesis dependent?
    J Natl Cancer Inst. 1990 Jan 3;82(1):4-6 PMID: 1688381
  17. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
    Science. 1999 Jun 18;284(5422):1994-8 PMID: 10373119
  18. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.
    J Clin Pathol. 1990 Sep;43(9):752-7 PMID: 2212067
  19. Tumor angiogenesis in human lung adenocarcinoma.
    Cancer. 1995 Jul 1;76(1):151 PMID: 8630867
  20. A novel lamina lucida component of epithelial and endothelial basement membranes detected by LH39 monoclonal antibody.
    J Pathol. 1992 Mar;166(3):243-53 PMID: 1517880
  21. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
    Cancer. 2001 Apr 15;91(8):1500-9 PMID: 11301398
  22. The distribution of LH39 basement membrane epitope in the tumour stroma of oral squamous cell carcinomas.
    J Pathol. 1992 Apr;166(4):369-74 PMID: 1381430
  23. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
    Clin Cancer Res. 1998 Nov;4(11):2625-34 PMID: 9829725
  24. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections.
    J Neurosurg. 1994 Dec;81(6):902-9 PMID: 7525899
  25. Angiogenesis in primary lung cancer and lung secondaries.
    Eur J Cancer. 1996 Dec;32A(14):2494-500 PMID: 9059338
  26. Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
    J Clin Oncol. 1997 Aug;15(8):2858-65 PMID: 9256129
  27. Role of arterial occlusion in pulmonary scar cancers.
    Hum Pathol. 1988 Oct;19(10):1161-7 PMID: 3169724
  28. Definition of two angiogenic pathways by distinct alpha v integrins.
    Science. 1995 Dec 1;270(5241):1500-2 PMID: 7491498
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
2002-01-21
Pages
244-9
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2375177
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com